Teknova to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Teknova (Nasdaq: TKNO) will report fourth-quarter and full-year 2025 financial results on February 26, 2026 after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teknova (Nasdaq: TKNO) will report fourth-quarter and full-year 2025 financial results on February 26, 2026 after market close.
The company will host a live webcast and conference call on February 26, 2026 at 5:30 p.m. Eastern Time, with a replay available on the investor website about two hours after the event.
Details
News Market Reaction – TKNO
On Feb 6, the first trading day after this news, TKNO closed 2.17% below the previous close.
Data tracked by StockTitan Argus for the Feb 6 session.
Key Figures
- Earnings release date
- February 26, 2026
- Q4 and full year 2025 financial results
- Fiscal year-end
- December 31, 2025
- Period covered by upcoming results
- Call time
- 5:30 p.m. Eastern Time
- Start of earnings webcast and conference call
- Replay timing
- ≈2 hours post-event
- Webcast replay availability on company website
Historical Context
-
Reported Q3 revenue growth, margin improvement, and narrower net loss.
-
Announced Q3 2025 earnings release date and post-close conference call.
-
Delivered Q2 revenue growth and higher gross margin with smaller net loss.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
molecular diagnostics medical
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
HOLLISTER, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026, following the close of market.
Teknova will host a webcast and conference call on Thursday, February 26, 2026, beginning at 5:30 p.m. Eastern Time. To access the live webcast, listeners can log onto the call from the Investor Relations section of the Teknova website or by using this link. If you would like to participate in the call, please register for the webcast here to receive a unique PIN number and dial-in information. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Teknova
Teknova makes solutions possible. Since 1996, Teknova has been innovating the manufacture of critical reagents for the life sciences industry to accelerate the discovery and development of novel breakthroughs that will help people live longer, healthier lives. We offer fully customizable solutions for every stage of the workflow, supporting industry leaders in molecular diagnostics, synthetic biology, and emerging therapeutic modalities. Our fast turnaround of high-quality agar plates, microbial culture media, buffers and reagents, and water helps our customers scale seamlessly from RUO to GMP. Headquartered in Hollister, California, with over 180,000 square feet of state-of-the-art facilities, Teknova’s modular manufacturing platform was designed by our team of scientists, engineers, and quality control experts to efficiently produce the foundational ingredients for the discovery and commercialization of next-generation therapies.
Investor Contact
Matt Lowell
Chief Financial Officer
matt.lowell@teknova.com
+1 831-637-1100
Media Contact
Jennifer Henry
Senior Vice President, Marketing
jenn.henry@teknova.com
+1 831-313-1259
This press release was published by a CLEAR® Verified individual.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.